{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:34:24Z","timestamp":1794558864983,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ascendis Pharma Growth Disorders, A\/S"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, there is limited research on how having a child diagnosed with achondroplasia affects parents\u2019 lives. The purpose of the study was to investigate the experiences of parents of infants and young children less than two years of age with achondroplasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Concept elicitation interviews were conducted with parents of children less than 2\u00a0years of age with achondroplasia in the United States and Spain. Using grounded theory methods modified for health outcomes research, a qualitative analysis of interview transcripts was conducted. Based on the qualitative analysis, a preliminary theoretical model of the experiences of parents of infants and young children with achondroplasia was developed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifteen parents, including 14 mothers and 1 father from 15 unique families, participated in individual or focus group concept elicitation interviews in the US (n\u2009=\u20099) and Spain (n\u2009=\u20096). The qualitative analysis identified four key parent impact domains, which included caretaking responsibilities, impacts on emotional well-being, having worries and concerns about their child, and impacts on daily well-being. Frequently discussed caretaking responsibilities among parents were managing child\u2019s medical care\/treatment (93%), obtaining adaptations\/items for child (73%), and monitoring child to avoid complications of achondroplasia (67%). Emotional impacts included feeling stressed\/overwhelmed (67%), depressed\/sad (40%), and anxious\/nervous (33%). Worries and concerns included worry\/concern about the future (100%), concerns regarding child\u2019s physical health (87%), worry about child\u2019s social well-being (80%), concern for child\u2019s emotional well-being (73%), and worry about child being able to function independently (67%). Daily well-being impacts included family strain (60%), missed work time (47%), and missed\/limited social activities (33%). Based on the qualitative findings, a preliminary theoretical model depicting the experiences of parents of infants and young children with achondroplasia was created.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study sheds light on the range of impacts that parents of infants and young children with achondroplasia may experience, including caretaking responsibilities, impacts on emotional well-being, worries\/concerns regarding their child, and impacts on daily well-being. The theoretical model of parent experiences may provide a helpful framework for informing future research and clinical practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01978-z","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T08:03:01Z","timestamp":1628236981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-6340","authenticated-orcid":false,"given":"Kathryn M.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-5838","authenticated-orcid":false,"given":"Meryl","family":"Brod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-534X","authenticated-orcid":false,"given":"Alden","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Viuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-8423","authenticated-orcid":false,"given":"Sho","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-9165","authenticated-orcid":false,"given":"R. Will","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"issue":"9582","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","volume":"370","author":"WA Horton","year":"2007","unstructured":"Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007;370(9582):162\u201372.","journal-title":"Lancet"},{"issue":"1","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0972-6","volume":"14","author":"RM Pauli","year":"2019","unstructured":"Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis. 2019;14(1):1.","journal-title":"Orphanet J Rare Dis"},{"issue":"39","key":"1978_CR3","doi-asserted-by":"publisher","first-page":"30103","DOI":"10.1074\/jbc.M109.094086","volume":"285","author":"L He","year":"2010","unstructured":"He L, Horton W, Hristova K. Physical basis behind achondroplasia, the most common form of human dwarfism. J Biol Chem. 2010;285(39):30103\u201314.","journal-title":"J Biol Chem"},{"issue":"9","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jmg.35.9.705","volume":"35","author":"AG Hunter","year":"1998","unstructured":"Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. Medical complications of achondroplasia: a multicentre patient review. J Med Genet. 1998;35(9):705\u201312.","journal-title":"J Med Genet"},{"issue":"2","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/adc.2010.189092","volume":"97","author":"MJ Wright","year":"2012","unstructured":"Wright MJ, Irving MD. Clinical management of achondroplasia. Arch Dis Child. 2012;97(2):129\u201334.","journal-title":"Arch Dis Child"},{"key":"1978_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/TACG.S51485","volume":"7","author":"PJ Ireland","year":"2014","unstructured":"Ireland PJ, Pacey V, Zankl A, Edwards P, Johnston LM, Savarirayan R. Optimal management of complications associated with achondroplasia. Appl Clin Genet. 2014;7:117\u201325.","journal-title":"Appl Clin Genet"},{"key":"1978_CR7","doi-asserted-by":"crossref","unstructured":"Trotter TL, Hall JG. American Academy of Pediatrics Committee on G. Health supervision for children with achondroplasia. Pediatrics. 2005;116(3):771\u201383.","DOI":"10.1542\/peds.2005-1440"},{"issue":"2","key":"1978_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11914-017-0347-2","volume":"15","author":"S Unger","year":"2017","unstructured":"Unger S, Bonafe L, Gouze E. Current care and investigational therapies in achondroplasia. Curr Osteoporos Rep. 2017;15(2):53\u201360.","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"e20201010","DOI":"10.1542\/peds.2020-1010","volume":"145","author":"J Hoover-Fong","year":"2020","unstructured":"Hoover-Fong J, Scott CI, Jones MC, Committee On Genetics. Health supervision for people with achondroplasia. Pediatrics. 2020;145(6):e20201010.","journal-title":"Pediatrics"},{"issue":"3","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/jpet.119.258251","volume":"370","author":"VM Breinholt","year":"2019","unstructured":"Breinholt VM, Rasmussen CE, Mygind PH, Kjelgaard-Hansen M, Faltinger F, Bernhard A, et al. TransCon CNP, a sustained-release C-type natriuretic peptide prodrug, a potentially safe and efficacious new therapeutic modality for the treatment of comorbidities associated with fibroblast growth factor receptor 3-related skeletal dysplasias. J Pharmacol Exp Ther. 2019;370(3):459\u201371.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10252","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0140-6736(20)31541-5","volume":"396","author":"R Savarirayan","year":"2020","unstructured":"Savarirayan R, Tofts L, Irving M, Wilcox W, Bacino CA, Hoover-Fong J, et al. Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial. Lancet. 2020;396(10252):684\u201392.","journal-title":"Lancet"},{"key":"1978_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12955-014-0151-y","volume":"12","author":"MJ Dogba","year":"2014","unstructured":"Dogba MJ, Rauch F, Douglas E, Bedos C. Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta. Health Qual Life Outcomes. 2014;12:151.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ajmg.a.20127","volume":"120A","author":"SE Gollust","year":"2003","unstructured":"Gollust SE, Thompson RE, Gooding HC, Biesecker BB. Living with achondroplasia in an average-sized world: an assessment of quality of life. Am J Med Genet A. 2003;120A(4):447\u201358.","journal-title":"Am J Med Genet A"},{"issue":"24","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1080\/09638288.2016.1226969","volume":"39","author":"R Sommer","year":"2017","unstructured":"Sommer R, Blomeke J, Dabs M, Witt S, Bullinger M, Quitmann J. An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia - development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES). Disabil Rehabil. 2017;39(24):2499\u2013503.","journal-title":"Disabil Rehabil"},{"issue":"15","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1080\/09638288.2018.1447028","volume":"41","author":"J Bloemeke","year":"2019","unstructured":"Bloemeke J, Sommer R, Witt S, Dabs M, Badia FJ, Bullinger M, et al. Piloting and psychometric properties of a patient-reported outcome instrument for young people with achondroplasia based on the International Classification of Functioning Disability and Health: the Achondroplasia Personal Life Experience Scale (APLES). Disabil Rehabil. 2019;41(15):1815\u201325.","journal-title":"Disabil Rehabil"},{"issue":"6","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1469-8749.2012.04234.x","volume":"54","author":"PJ Ireland","year":"2012","unstructured":"Ireland PJ, Donaghey S, McGill J, Zankl A, Ware RS, Pacey V, et al. Development in children with achondroplasia: a prospective clinical cohort study. Dev Med Child Neurol. 2012;54(6):532\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/DBP.0b013e3181c72052","volume":"31","author":"PJ Ireland","year":"2010","unstructured":"Ireland PJ, Johnson S, Donaghey S, Johnston L, McGill J, Zankl A, et al. Developmental milestones in infants and young Australasian children with achondroplasia. J Dev Behav Pediatr. 2010;31(1):41\u20137.","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13023-019-1171-9","volume":"14","author":"S Witt","year":"2019","unstructured":"Witt S, Kolb B, Bloemeke J, Mohnike K, Bullinger M, Quitmann J. Quality of life of children with achondroplasia and their parents\u2014a German cross-sectional study. Orphanet J Rare Dis. 2019;14(1):194.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1978_CR19","first-page":"51","volume":"32","author":"JS Coffey","year":"2006","unstructured":"Coffey JS. Parenting a child with chronic illness: a metasynthesis. Pediatr Nurs. 2006;32(1):51\u20139.","journal-title":"Pediatr Nurs"},{"issue":"1","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1367493511420186","volume":"16","author":"D McCann","year":"2012","unstructured":"McCann D, Bull R, Winzenberg T. The daily patterns of time use for parents of children with complex needs: a systematic review. J Child Health Care. 2012;16(1):26\u201352.","journal-title":"J Child Health Care"},{"issue":"4","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.dhjo.2015.03.009","volume":"8","author":"LJ Pelentsov","year":"2015","unstructured":"Pelentsov LJ, Laws TA, Esterman AJ. The supportive care needs of parents caring for a child with a rare disease: a scoping review. Disabil Health J. 2015;8(4):475\u201391.","journal-title":"Disabil Health J"},{"issue":"1","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11136-020-02594-3","volume":"30","author":"KM Pfeiffer","year":"2021","unstructured":"Pfeiffer KM, Brod M, Smith A, Gianettoni J, Viuff D, Ota S, et al. Assessing the impacts of having a child with achondroplasia on parent well-being. Qual Life Res. 2021;30(1):203\u201315.","journal-title":"Qual Life Res"},{"issue":"10","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1469-8749.2011.04050.x","volume":"53","author":"PJ Ireland","year":"2011","unstructured":"Ireland PJ, McGill J, Zankl A, Ware RS, Pacey V, Ault J, et al. Functional performance in young Australian children with achondroplasia. Dev Med Child Neurol. 2011;53(10):944\u201350.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajmg.a.20201","volume":"122A","author":"V Hill","year":"2003","unstructured":"Hill V, Sahhar M, Aitken M, Savarirayan R, Metcalfe S. Experiences at the time of diagnosis of parents who have a child with a bone dysplasia resulting in short stature. Am J Med Genet A. 2003;122A(2):100\u20137.","journal-title":"Am J Med Genet A"},{"issue":"Suppl 1","key":"1978_CR25","first-page":"109","volume":"15","author":"S Witt","year":"2017","unstructured":"Witt S, Rohenkohl A, Bullinger M, Sommer R, Kahrs S, Klingebiel KH, et al. Understanding, assessing and improving health-related quality of life of young people with achondroplasia\u2014a collaboration between a patient organization and academic medicine. Pediatr Endocrinol Rev. 2017;15(Suppl 1):109\u201318.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"8","key":"1978_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/jpepsy\/jst049","volume":"38","author":"MK Cousino","year":"2013","unstructured":"Cousino MK, Hazen RA. Parenting stress among caregivers of children with chronic illness: a systematic review. J Pediatr Psychol. 2013;38(8):809\u201328.","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"1978_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1037\/fsh0000305","volume":"36","author":"JL Crandell","year":"2018","unstructured":"Crandell JL, Sandelowski M, Leeman J, Havill NL, Knafl K. Parenting behaviors and the well-being of children with a chronic physical condition. Fam Syst Health. 2018;36(1):45\u201361.","journal-title":"Fam Syst Health"},{"issue":"9","key":"1978_CR28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11136-009-9540-9","volume":"18","author":"M Brod","year":"2009","unstructured":"Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18(9):1263\u201378.","journal-title":"Qual Life Res"},{"issue":"8","key":"1978_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396.","journal-title":"Qual Life Res"},{"issue":"8","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2013assessing respondent understanding. Value Health. 2011;14(8):978\u201388.","journal-title":"Value Health"},{"issue":"8","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967\u201377.","journal-title":"Value Health"},{"issue":"1","key":"1978_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ajmg.a.61903","volume":"185","author":"KM Pfeiffer","year":"2021","unstructured":"Pfeiffer KM, Brod M, Smith A, Gianettoni J, Viuff D, Ota S, et al. Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia. Am J Med Genet A. 2021;185(1):33\u201345.","journal-title":"Am J Med Genet A"},{"key":"1978_CR33","unstructured":"Dedoose Version 8.0.35, web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles, CA: SocioCultural Research Consultants, LLC; 2018. Available from: https:\/\/www.dedoose.com\/."},{"issue":"6","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/GIM.0b013e3181daae9b","volume":"12","author":"D Krakow","year":"2010","unstructured":"Krakow D, Rimoin DL. The skeletal dysplasias. Genet Med. 2010;12(6):327\u201341.","journal-title":"Genet Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01978-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T08:10:02Z","timestamp":1628237402000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01978-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01978-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Copernicus Group Institutional Review Board, Protocol numbers: TBG1-18\u2013117 and 20190578) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all parent participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K. Pfeiffer and M. Brod are paid consultants to the pharmaceutical industry, including Ascendis Pharma. A. Smith is an employee of Ascendis Pharma, Inc. D. Viuff is an employee of Ascendis Pharma, A\/S. R.W. Charlton and S. Ota were employees of Ascendis Pharma, Inc. at the time this research was conducted<b>.<\/b>","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}